Rothblatt Martine A

Chairperson &CEO | Director

2 companies

Insider Signal Score

Good

Trades Analyzed

304

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at United Therapeutics Corporation with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 114 sells.

Estimated insider holdings value: $173.5M based on current market prices.

Holdings by Company

UTHRJul 30, 2026

Current Shares333.9K

Value$173.32M

Net Activity-397,910

Bought: 0Sold: 397.9K

BETAJun 11, 2026

Current Shares8.2K

Value$182.3K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 23, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$543.95	$5,167,570.77	-2.9%	-	-
Jun 22, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	8,638	$538.03	$4,647,529.73	-2.7%	-	-
Jun 16, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$549.80	$5,223,068.48	-2.1%	-	-
Jun 1, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$547.91	$5,205,104.61	-2.4%	-	-
May 29, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$553.83	$5,261,365.38	-1.7%	-	-
May 12, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$578.38	$5,494,562.96	-1.5%	-	-
Apr 20, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	8,470	$577.29	$4,889,655.40	-1.4%	-7.7%	-
Mar 16, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$537.81	$5,109,148.28	-16.5%	+2.2%	-
Mar 11, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	9,500	$539.54	$5,125,646.80	-14.7%	+1.5%	-
Mar 10, 2026	UTHR United Therapeutics Corporation	Chairperson &CEO	Sale+OE	8,890	$540.05	$4,801,041.55	-10.1%	+2.6%	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC